Bausch Health Companies (BHC) Free Cash Flow (2009 - 2026)
Bausch Health Companies (BHC) posted Free Cash Flow of $593.0 million for Q2 2026, up 390.08% sequentially from $121.0 million in Q1 2026, and up 212.11% YoY from $190.0 million in Q2 2025.
Bausch Health Companies (BHC) Free Cash Flow (2009 - 2026) Analysis & Trends
Bausch Health Companies has reported Free Cash Flow for 18 years, with the latest figure at $593.0 million in Q2 2026.
- Quarterly Free Cash Flow rose 212.11% year-over-year to $593.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $1.4 billion (up 28.34% YoY) and the FY2025 annual result came in at $1.0 billion, down 20.4% from the prior year.
- Free Cash Flow improved to $593.0 million in Q2 2026 per BHC's latest filing, from $121.0 million in the prior quarter.
- Over five years, Free Cash Flow peaked at $593.0 million in Q2 2026 and troughed at -$1.3 billion in Q3 2022.
- A 5-year average of $158.2 million and a median of $215.0 million in 2023 frame the typical range for Free Cash Flow.
- The widest YoY moves for Free Cash Flow: up 857.41% in 2022, down 362.87% in 2022.
- Over 5 years, Free Cash Flow stood at $409.0 million in 2022, then dropped by 28.61% to $292.0 million in 2023, then jumped by 69.52% to $495.0 million in 2024, then slipped by 18.59% to $403.0 million in 2025, then surged by 47.15% to $593.0 million in 2026.
- According to Business Quant data, Free Cash Flow over the past three periods registered $593.0 million, $121.0 million, and $403.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 307.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 538.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 1.14 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 205.60 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 329.00 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 128.60 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 244.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Bausch Health Companies | 2.42 Bn | 586.38 Mn | 2.10 Bn | 593.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 593.00 Mn |
| Jun 30, 2026 | 593.00 Mn |
| Mar 31, 2026 | 121.00 Mn |
| Mar 31, 2026 | 121.00 Mn |
| Dec 31, 2025 | 403.00 Mn |
| Dec 31, 2025 | 403.00 Mn |
| Sep 30, 2025 | 314.00 Mn |
| Sep 30, 2025 | 314.00 Mn |
| Jun 30, 2025 | 190.00 Mn |
| Jun 30, 2025 | 190.00 Mn |
| Mar 31, 2025 | 96.00 Mn |
| Mar 31, 2025 | 96.00 Mn |
| Dec 31, 2024 | 495.00 Mn |
| Dec 31, 2024 | 495.00 Mn |
| Sep 30, 2024 | 334.00 Mn |
| Sep 30, 2024 | 334.00 Mn |
| Jun 30, 2024 | 302.00 Mn |
| Jun 30, 2024 | 302.00 Mn |
| Mar 31, 2024 | 129.00 Mn |
| Mar 31, 2024 | 129.00 Mn |